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Abstract
Background: Although sucrose has been accepted as an effective analgesic agent for procedural
pain in neonates, previous studies are largely in the NICU population using the procedure of heel
lance. This is the first report of the effect of sucrose, pacifier or the combination thereof for the
procedural pain of venipuncture in infants in the pediatric emergency department population.
Methods: The study design was a double (sucrose) and single blind (pacifier), placebo-controlled
randomized trial – factorial design carried out in a pediatric emergency department. The study
population was infants, aged 0 – 6 months. Eighty-four patients were randomly assigned to one of
four groups: a) sucrose b) sucrose & pacifier c) control d) control & pacifier. Each child received 2
ml of either 44% sucrose or sterile water, by mouth. The primary outcome measure: FLACC pain
scale score change from baseline. Secondary outcome measures: crying time and heart rate change
from baseline.
Results: Sucrose did not significantly reduce the FLACC score, crying time or heart rate. However
sub-group analysis revealed that sucrose had a much greater effect in the younger groups. Pacifier
use reduced FLACC score (not statistically significant), crying times (statistically significant) but not
heart rate. Subgroup analysis revealed a mean crying time difference of 76.52 seconds (p < 0.0171)
(0–1 month) and 123.9 seconds (p < 0.0029) (1–3 month). For subgroup age > 3 months pacifier
did not have any significant effect on crying time. Age adjusted regression analysis revealed that
both sucrose and pacifier had significant effects on crying time. Crying time increased with both
increasing age and increasing gestational age.
Conclusion: Pacifiers are inexpensive, effective analgesics and are easy to use in the PED for
venipuncture in infants aged 0–3 months. The benefits of sucrose alone as an analgesic require
further investigation in the older infant, but sucrose does appear to provide additional benefit when
used with a pacifier in this age group.
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Background
To facilitate proper assessment, diagnosis and manage-
ment many children must undergo painful procedures
such as venipuncture for blood work or treatment, mak-
ing the emergency department an ideal location to evalu-
ate effective methods of pain control. Research suggests
that prompt and accurate recognition and treatment of
pain in young infants is important for their immediate
comfort and for their best possible lifelong development
[1,2]. Despite the recent interest in pediatric pain assess-
ment, prevention and treatment, many children are still
not adequately treated to alleviate pain [[1,3], and [4]].
The ideal analgesic for procedural pain in the emergency
department should have quick onset, be effective, and
have no side effects. Sucrose has been extensively studied
as analgesia for short procedures such as heel lance in
neonates. A Cochrane systematic review concluded that
sucrose is safe and effective in reducing procedural pain
from single short procedural events in neonates [5].
This taste-induced analgesia is thought to be mediated by
endogenous opiod mechanisms [[6,7], and [8]] although
has been questioned in other papers. Gradin et al have
demonstrated that administration of an opiod antagonist
to newborns did not reduce the pain relieving effect of
oral glucose [9]. This contradicts findings in previous ani-
mal studies. Also, Eriksson et al showed that tolerance did
not develop in neonates who were given repeated doses of
glucose [10]. Infants receiving immunizations up to 12
months of age had similar findings [11]. Other theories
for the analgesic actions of sucrose are through non-opiod
endogenous pain inhibiting systems, activation of the
pleasure center with dopamine release and initiation of
the sucking response.
The effect of non-nutritive sucking using pacifiers has also
been studied in neonates. Sucking is thought to trigger
release of serotonin, which may modify the perception of
pain. In general the magnitude of the decrease in pain is
greater when sucking and sucrose are combined than with
sucking alone [7].
From the neonatal literature, which most frequently
examined pain responses to heel lance, it seems that
sucrose is a safe, easy-to-administer, inexpensive and
effective analgesic for short painful procedures. A growing
number of studies, looking at infants undergoing immu-
nizations, suggest that this analgesic effect may indeed
extend past the neonatal period into infancy [11-16]. Nev-
ertheless, the upper limit of this effect is unknown in
terms of age and appropriate sucrose strength. Also, the
analgesic effect of non-nutritive sucking for infants older
than one month has not been previously studied.
We wished to know if the analgesic effect of sucrose or
pacifier holds true for neonates and young infants in the
emergency department, particularly for the procedure of
venipuncture, which unlike heel lance and intramuscular
injection, is commonly performed in that setting. Patients
frequenting the emergency department generally differ in
physiology and pathology from that of neonates in inten-
sive care units where the majority of previous studies were
carried out. We anticipated that this study would provide
direction as to whether the use of sucrose, plus or minus
pacifiers, as analgesia for venipuncture is useful for infants
undergoing assessment in pediatric emergency depart-
ments.
Methods
Location
This study took place at the Pediatric Emergency Depart-
ment at the Stollery Children's Hospital in Edmonton,
Alberta, Canada. The Stollery Children's Hospital houses
the only specialized pediatric emergency in central and
northern Alberta and has one of the largest catchment
areas in North America with its referral base of more than
1.7 million. The PED sees 50 to 60 children per day with
annual figures totaling just over 20,000 patients. Approx-
imately 15 per cent of these emergency patients require
admission to hospital.
Protocol
This study received approval from the hospital's institu-
tional ethics review board, the department of pediatrics
and from the division of emergency medicine. Figure 1
outlines the study flow.
Study population
All infants up to 6 months corrected age that required ven-
ipuncture as part of their emergency department manage-
ment were eligible for the study. Participants were
required to have had nothing by mouth for 5 minutes
prior to study commencement. Previous animal and
human studies have shown that sucrose analgesia lasts for
Study Flow Diagram Figure 1
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up to five minutes. Exclusion criteria included any infant
deemed critically ill at the discretion of the attending phy-
sician, fructose intolerance, and EMLA application at site
of venipuncture.
Blinded randomization
The subjects were randomized to the treatment groups
using computer-generated block randomization organ-
ized by the hospital research pharmacist. Each pre-pre-
pared syringe holding either sucrose or sterile water was
labeled by numbers 1–84 and was indistinguishable by
color, smell and flow during administration. The study
syringes were placed in a sealed package and stored in a
fridge in an area of the ED to which only the ED nurses
had access. After written informed consent was obtained,
the study nurse obtained the next labeled syringe. The
number on the syringe was recorded with the patient's
data and on a separate list containing the patient's name,
which was kept separate from the data.
The research pharmacist held the numbered code list con-
taining the identity of the solution used in each syringe
until the study had officially ended and data analysis was
completed. It was then released to the primary author and
statistician so that correct identification of groups could
occur. Thus throughout the study all of the researchers,
outcome assessors, subjects and statistician were blinded
to the identities of the solutions.
Pacifier use could not be blinded to the research nurse or
parent since visualization of the face was required to score
the primary outcome measure. The addition of a second
research nurse to stand behind a curtain to take crying
time measurements would have added considerable
expense to the study and was not feasible. Random assign-
ment of pacifier use was again computer generated by the
pharmacist, so that each numbered syringe included
instructions to use or omit pacifier. The researchers and
statistician were blinded as to which patients had used
pacifiers until after completion of analysis.
Outcome measurements
The pain related to venipuncture was primarily measured
using the Face, Legs, Activity, Cry, and Consolability Pain
Scale (FLACC) [17-19]. This scale was validated by Merkel
et al for measurement of pain in preverbal or cognitively
impaired children, and is used by the pediatric pain serv-
ice at SCH. The FLACC tool assesses changes in the above
five categories of behavior, rating each on a scale of 0–2
(Table 1). Ten is the maximum score indicating severe
pain and a score < 2 generally indicates absence of pain.
FLACC scores were assessed before procedure and after
venipuncture and change from baseline was our outcome
measure. Interrater reliability for this scale has been dem-
onstrated to be acceptable as kappa values for each of the
five categories range between 0.52 and 0.82. It is generally
acknowledged that interrater reliability coefficients over
0.41 demonstrate acceptable agreement between users
[19]. Several different research nurses were trained by our
research nurse coordinator in performing FLACC scores
and other details related to outcome assessment prior to
each of the study periods. One refresher session was
offered throughout each study period also to ensure skills
remained consistent.
Because pediatric pain in young infants is so difficult to
clearly identify, we felt that it would be prudent to use
other secondary outcome measures such as crying time
and heart rate. Both of these measures have been widely
used in the neonatal studies on sucrose efficacy for proce-
dural pain, and crying time has been used as the primary
outcome measure in many [2,4], and [5]. Crying time was
monitored by a stopwatch from the infant's first cry after
venipuncture and recorded as the number of seconds that
vocalizations were sustained, up to 5 minutes. From pre-
vious studies of similar procedures, the majority, but not
all infants ceased to cry within three-minutes [15]. Heart
rate was measured pre procedure and at 1 minute intervals
after the procedure for 5 minutes. The heart rate outcome
measure is the difference between the highest value
recorded over that 5-minute period and the baseline
Table 1: FLACC pain scale
Categories Scoring
01 2
Face No particular expression or smile Occasional grimace or frown, withdrawn, 
disinterested.
Frequent to constant quivering chin, 
clenched jaw.
Legs Normal position or relaxed Uneasy, restless, tense. Kicking, or legs drawn up.
Activity Lying quietly, normal position moves easily Squirming, shifting back and forth, tense. Arched, rigid or jerking.
Cry No cry, (awake or asleep) Moans or whimpers; occasional complaint Crying steadily screams or sobs, 
frequent complaints.
Consolability Content, relaxed. Reassured by occasional touching hugging 
or being talked to, distractible.
Difficulty to console or comfort.
Adapted from The FLACC: A behavioral scale for scoring postoperative pain in young children, by S Merkel and others, 1997, Pediatr Nurse 23(3), 
p. 293–297. Copyright 1997 by Jannetti Co. University of Michigan Medical Center.BMC Pediatrics 2007, 7:27 http://www.biomedcentral.com/1471-2431/7/27
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measure recorded prior to the procedure. We alighted
upon this method of assessing heart rate from a review of
previous studies in this area as it is commonly used as an
outcome measure and seemed reasonable and similar in
concept to those previous studies [5]. For the FLACC
score, the outcome measure is the difference between pre
and post procedure.
Data collection
All patients aged 0 – 6 months who arrived during study
hours were identified in the PED, and the research nurse
was contacted. The research nurse recruited and followed
patients if eligible. Eligible patients were those meeting
inclusion and exclusion criteria. The research nurse
explained the study to the family, obtained written con-
sent and gathered some baseline information about the
subjects' past medical history. Patients were randomly
assigned to one of four groups as follows: a) sucrose b)
sucrose & pacifier c) placebo d) placebo & pacifier. Each
child received, by mouth, 2 ml of either 44% sucrose or
sterile water, two minutes prior to venipuncture. These
solutions were prepared and coded in advance by phar-
macy such that all other study participants and investiga-
tors were blinded to their identity.
Timers were used by the research nurse to coordinate all
of the following events. The solution was administered by
the research nurse to the anterior aspect of the tongue over
30 seconds via syringe and a pacifier was inserted orally
according to randomization. At 2 minutes after com-
mencement of solution administration, venipuncture
took place as performed by the PED nurses and as per
standard nursing practice. Parents interacted with voice or
touch as per normal.
The research nurse collected all data. Baseline vitals such
as temperature, weight and BP were recorded. A baseline
pain score pre- venipuncture was assigned by the research
nurse using the FLACC scale. Each child had continuous
cardiac and oxygen saturation monitoring throughout the
intervention and data collection. Heart rate and oxygen
saturation were noted each minute over a 5-minute period
post venipuncture. Crying time post venipuncture was
measured by stopwatch. The research nurse assigned a
FLACC score between 30 seconds and one minute after
the procedure. If initial venipuncture was unsuccessful, a
second attempt only took place after the full 5-minute
interval. All data was recorded on a data collection sheet
and was entered into a spreadsheet by the research nurse
for analysis. The research nurse called each participant
within 72 hours to assess for adverse effects. All documen-
tation was locked in a secure cabinet, kept confidential for
the length of the study and will be destroyed in five years.
Data was entered into Microsoft Excel by the research
nurse. The data was later downloaded into S- Plus where
the majority of the data-analysis was done.
Data analysis
Sample size
Based on previous measurements of pain on the Prema-
ture Infant Pain Profile (PIPP- a 20 point scale), we esti-
mated that the standard deviation of pain scores on the
FLACC scale (a 10 point scale) to be approximately 1.75.
Assuming an alpha level of 0.05 and a power of 90%, we
required a total sample size of 84 infants to be able to
detect a 1.25 -point average FLACC scale difference
between two groups using a paired t-test. Sample size was
based on our primary variable of interest and primary out-
come (sucrose/pacifier effect on pain reduction) and cal-
culated using nQuery Advisor version 4.0. Although
pacifier/sucrose interaction effect was unknown we
assumed no interaction in making this calculation.
Statistical analysis
A two-way analysis of variance was used to ascertain any
interaction effects between our primary variables. Differ-
ences in intervention groups were computed both in
unadjusted (via unpaired t-tests) and adjusted (via regres-
sion analysis) analyses for all continuous outcomes of
interest (i.e. FLACC change score, crying time, and maxi-
mum heart rate difference). For the adjusted analysis, co-
variates included in the regression were age, sex, weight,
NPO time, and gestational age. The gestational ages for
nine children were unavailable, and thus the mean of the
remainder of the children was used to impute a value for
these nine for purposes of the regression analysis.
The intention to treat principle was used in all our analy-
ses – all subjects were analyzed in the groups to which
they were initially assigned. Means, standard deviations,
and/or 95% confidence intervals are presented for all con-
tinuous outcomes. P-values of statistical tests are pre-
sented for all outcomes.
Results
Over two 3-month periods from February 2004 – June
2005, 87 patients were assessed for eligibility and 84 were
randomized to the four groups. Timing of recruitment was
dependent on research nurse availability, patient volume
and cost. Two parents refused to participate and one
patient was deemed too ill to engage in the study. Baseline
characteristics of subjects in all groups are presented in
Table 2. Most of the baseline characteristics were similar
and did not differ between study periods. The most nota-
ble difference was that by chance the pacifier & placebo
group had a mean and median age that was half of the
other three groups. This group also had the highest admis-
sion rate. The baseline FLACC score and heart rates were
similar between the groups. None of the babies were cry-BMC Pediatrics 2007, 7:27 http://www.biomedcentral.com/1471-2431/7/27
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ing before venipuncture occurred. All of the subjects had
successful initial IV attempts.
Table 3 presents the means and 95% confidence intervals
of the outcome variables by the four study groups. The
ANOVA did not show any signs of an interaction effect
between pacifier and sucrose with respect to any of the
outcomes examined, thus direct t-test comparisons could
be used to ascertain the effects of both sucrose and pacifier
using the full sample.
Unadjusted effects
Estimates for FLACC score and heart rate are presented as
mean change from baseline ± standard deviation.
Sucrose
The FLACC score in the 43 sucrose infants increased from
baseline by an average of 3.2 ± 3.6 which was not signifi-
cantly different from the 3.6 ± 3.3 average of the 41 pla-
cebo infants (p = 0.66). There were also no significant
differences in crying time (sucrose: 168.4 ± 112.2, pla-
cebo: 200.7 ± 96.0; p = 0.16) or heart rate change (sucrose:
28.1 ± 29.3, placebo: 26.4 ± 18.7; p = 0.75).
Pacifier
The 40 infants that did not receive a pacifier had an aver-
age increase from baseline in FLACC score of 4.3 ± 4.5
compared to the average increase from baseline of 2.5 ±
3.7 in the 44 infants that did receive a pacifier. The differ-
ence between the two groups was very close to being sta-
tistically significant (p = 0.06). The difference in crying
time between the two groups was statistically significant
(pacifier: 143.3 ± 101.7, no pacifier: 229.1 ± 90.6; p =
0.0001) while the difference in heart rate change was not
(pacifier: 30.6 ± 27.7; no pacifier: 23.7 ± 20.4; p = 0.20).
Adjusted effects
We ran a regression analysis on our three outcomes
(FLACC difference, crying time, and heart rate difference)
including our two interventions, as well as age, sex,
weight, NPO time, and gestational age.
For change in FLACC score, age was the only variable that
was found to significantly affect the pain score (older chil-
dren experienced more pain, p = 0.006). Neither sucrose
nor pacifier was found to significantly affect FLACC score
change.
It was a different story with crying time, as both sucrose
(sucrose group 47.6 ± 18.8 seconds less crying time than
placebo; p = 0.01) and pacifier (pacifier group 80.5 ± 18.7
seconds less crying time than no pacifier; p < 0.0001) had
significant effects. Crying time increased with both
increasing age (older children cried longer, p < 0.0001)
and increasing gestational age (children with higher gesta-
tional age cried longer, p = 0.02). This was estimated such
that every week of age gain resulted in crying 8.5 seconds
longer.
For change in heart rate, none of our co-variates had a sig-
nificant effect.
Table 3: Mean variables and 95% confidence intervals of the four groups
Sucrose Placebo Pacifier & Sucrose Pacifier & Placebo
N = 21 19 22 22
FLACC Difference 3.71 (1.58, 5.84) 4.84 (2.80, 6.88) 2.64 (0.88, 4.40) 2.45 (0.92, 3.98)
Crying Time (sec) 209.1 (162.1, 255.2) 251.2 (215.8, 286.7) 129.6 (80.7, 178.4) 157.0 (115.9, 198.1)
Heart rate (bpm) 19.6 (9.1, 30.2) 28.2 (20.3, 36.0) 36.2 (17.7, 46.7) 24.9 (15.6, 34.2)
Table 2: Mean clinical and demographic characteristics of the four groups
Mean Values (Standard Deviation) Sucrose N = 21 Placebo N = 19 Pacifier & Sucrose N = 22 Pacifier & Placebo N = 22
Age (days) 63 (71) 64 (55) 68 (61) 38 (39)
Weight (kg) 4.7 (1.8) 4.9 (1.4) 4.9 (1.2) 4.2 (1.1)
Gest Age (wks) 37 (3.9) 39 (1.3) 39 (2.9) 38 (2.1)
NPO (min) 43 (36) 43 (60) 73 (169) 42 (50)
Rectal Temp (°C) 37 (1.0) 37 (0.9) 37 (0.6) 37 (0.8)
O2 Sat (%) 97 (2.0) 96 (2.3) 97 (2.0) 97 (2.8)
Resp Rate (bpm) 40 (8.5) 40 (10.7) 40 (10.6) 40 (10.4)
Male Sex 11 13 11 9
Admitted 13 12 14 17
Previous Analgesia 02 5 2BMC Pediatrics 2007, 7:27 http://www.biomedcentral.com/1471-2431/7/27
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Subgroup analysis
The results of the regression analysis prompted us to do a
post-hoc subgroup analysis, stratifying by age. We divided
the children into three subgroups: 0–1 month, 1–3
months, and 3–6 months (Tables 4 and 5).
Due to the small sample sizes in this analysis, none of the
subgroups showed a statistically significant difference for
either pacifier or sucrose with respect to change from base-
line in FLACC score, although interestingly both interven-
tions showed much greater effect in the 0–1 month and
1–3 month groups than the older than 3 month group.
For crying time, the sucrose intervention was not signifi-
cant in any of the three groups, but again showed greater
improvement in the younger two groups. Crying time was
significantly reduced for pacifier versus non-pacifier in
both the 0–1 month and 1–3 month groups, despite the
small sample sizes. Subgroup analysis revealed a mean
crying time difference of 76.52 seconds (p < 0.0171) (0–1
month) and 123.9 seconds (p < 0.0029) (1–3 month).
For subgroup age > 3 months pacifier did not have any sig-
nificant effect on crying time.
Other
The only adverse event that was noted was one episode of
vomiting which occurred in a total of three children, one
in each of the groups except for the sucrose only group.
Discussion
Our results suggest that venipuncture is a procedure that
causes moderate pain in infants. A FLACC score increase
of 4.84 (placebo group), post venipuncture falls into the
rating of moderate pain as per the authors of the FLACC
scale [17-19].
Currently the standard practice during venipuncture in
young infants in the PED is not to administer any analge-
sia. Even though neonatal studies have previously demon-
strated the effectiveness of sucrose and/or pacifiers, this
practice has not been adopted in general in emergency
departments as well as other pediatric departments [20].
We hope that this study will demonstrate the ease of use
of sucrose and/or pacifier and we hope that this will
inspire practice change in this area.
Our choices of outcome measures were a result of a review
of the literature. It should be noted that without direct ver-
bal corroboration from the infants we cannot be entirely
sure that any of the above outcome measures actually
reflect degree of pain. Previous studies have relied on
assessments of behavioral and physiological changes as
indirect indicators of pain. We felt that the most compre-
hensive approach was to use a combination of a validated
pain scale, total crying time and change in heart rate. The
FLACC scale uses parameters similar to many of the neo-
natal pain scales, is highly reliable, has been validated, is
very easy to use and teach and was best suited to the age
group we wished to study. Although crying is associated
with pain, it is not exclusive to pain, and thus must be
interpreted with caution. In this study, none of the infants
were crying prior to the procedure and all cried after it, so
it is likely that the pain of this procedure induced this
behavioral response. Thus we feel that in this study, crying
time is a reasonable measure of pain or discomfort and
have interpreted the results in such a light.
Our results show that pacifier appears to be an effective
analgesic for the procedural pain of venipuncture in
infants. Even though statistical significance was only nar-
rowly missed for the primary outcome measure (p= 0.06),
a change in average FLACC score from 4.3 (no pacifier) to
2.5 (pacifier) would be considered by most to be of clini-
cal significance. Pacifier use significantly reduced crying
time (statistically and clinically), particularly in the 0–3
month age group, despite small sample sizes of sub-group
analysis. It is promising to see that this analgesic effect
seems to extend beyond the neonatal period, perhaps up
to three months of age. It appears that the effect wanes
with age beyond three months. Further trials with larger
sample sizes in this age group would be helpful to clarify
this matter however.
Table 4: Differences between sucrose and placebo with 95% confidence intervals
n Change in FLACC score Crying Time (seconds) Change in heart rate (bpm)
Total Sample
Unadjusted 84 -0.40 (-2.20, 1.41) -32.3 (-77.7, 13.1) 1.7 (9.0, -12.4)
Adjusted 84 -0.86 (-2.50, 0.78) -47.6 (-84.5, -10.7) 0.9 (-9.8, 11.6)
Unadjusted Results by Age Groups
0–1 month 36 -1.22 (-3.50, 1.06) -52.7 (-117.5, 12.2) -3.6 (-16.7, 9.6)
1–3 months 28 -1.66 (-5.27, 1.96) -52.2 (-142.1, 37.6) 4.6 (-20.2, 29.3)
3–6 months 20 1.50 (-1.82, 4.82) 6.3 (-61.9, 74.5) 6.9 (-14.3, 28.0)BMC Pediatrics 2007, 7:27 http://www.biomedcentral.com/1471-2431/7/27
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One caution in the interpretation of results surrounding
pacifier use was the fact that the observer was not blinded.
This presents potential bias that was unavoidable for the
primary outcome measure assessment, as it was necessary
to look closely at the infants' faces to give a rating to this
parameter on the FLACC scale. The addition of a second
observer for the outcome measure of crying time would
nearly have doubled the budget of our study and was thus
impractical in our setting.
Also, heart rate measurements were assessed at the minute
marks only and it is possible that these data points do not
accurately represent interim variabilities. This may explain
why differences in heart rate were not found. Another pos-
sibility is that heart rate monitoring may not be a reliable
indicator of the amount of pain experienced. One adult
study observed a decrease in heart rate in some patients,
likely due to vagal stimulation, on insertion of an IV [21].
Two adult observational studies have noted lack of corre-
lation of heart rate with pain or changes in pain intensity
[21,22]. Review of neonatal studies reveals that heart rate
data collection methodology is highly variable and there
often does seem to be dissociation between pain scale
findings and physiological responses such as heart rate
[5,23]. Pereira et al evaluated the validity of heart rate
measurements for neonatal pain assessment in an RCT
and concluded that heart rate variations are an inconsist-
ent and insensitive way to evaluate pain in that popula-
tion [24]. Further clarification as to the reliability of this
outcome measure as an indicator of pain across the pedi-
atric spectrum may be warranted.
For sucrose as analgesia, the results are less clear. T-test
results demonstrated no significant benefit; however age
adjusted regression analysis showed significant reduction
in crying time. Trends seem to show greater reduction in
the younger age sub-groups. Sucrose appears to be less
effective with increasing age at the dosage studied. Further
study with larger sample sizes and perhaps using stronger
concentrations of sucrose would be required to determine
the upper age limit for the effectiveness of sucrose. It
seems that sucrose and pacifier have an additive beneficial
effect when used together and perhaps this is where the
best use for sucrose as analgesia lies- to be used in con-
junction with pacifier.
One must consider the dose of sucrose used. We chose
0.88 g (2 ml of a 44% solution) as this was easily prepared
by our pharmacy, which uses an 88% sucrose solution to
mix oral pediatric medications, and diluted this solution
for the purposes of our study. Doses up to 0.5 g have been
studied and determined to be safe for use in the neonatal
period [5] and immunization studies have used doses as
high as 2.5 g for older infants [14,16] without adverse
events. Future studies could look closely at the issue of
optimal doses, especially with older infants.
There are several limitations to our study. One limitation
to our study was that the study population was a conven-
ience sample of patients and a few potentially eligible
patients were not enrolled. The research nurses were avail-
able for 8–16 hours during the day so some children arriv-
ing overnight may have been missed. It is unlikely,
however that these children would have been different
from our study population.
Another limitation of this study was that despite accurate
randomization, our randomization produced somewhat
of an "unlucky sample" in that there were imbalances in
some of the baseline statistics particularly age, NPO, and
rate admitted. NPO was found in our adjusted analyses to
not have an effect on our outcomes, while admission rates
were not too unbalanced, and would be unlikely to have
an effect on our final outcomes. Due to our determination
in the adjusted analysis that, older children tend to expe-
rience more pain, the lower age in the pacifier/placebo
group could lead to slight overestimation of pain relief in
pacifiers and an underestimation of pain relief in the
sucrose. These results may need to be interpreted with
caution.
Table 5: Differences between pacifier and no pacifier with 95% confidence intervals
n Change in FLACC score Crying Time (seconds) Change in heart rate (bpm)
Total Sample
Unadjusted 84 -1.70 (-3.47, 0.07) -85.8 (-127.8, -43.8) 6.9 (-3.8, 17.5)
Adjusted 84 -1.44 (-3.08, 0.20) -80.5 (-117.1, -43.9) 8.1 (-2.7, 18.9)
Unadjusted Results by Age Groups
0–1 month 36 -1.77 (-4.01, 0.47) -76.5 (-138.6, -14.5) 9.3 (-3.6, 22.1)
1–3 months 28 -2.08 (-5.66, 1.50) -123.9 (-201.6, -46.3) 0.9 (-23.9, 25.7)
3–6 months 20 -0.70 (-4.02, 2.62) -42.4 (-105.9, 21.1) 11.2 (-9.0, 31.4)BMC Pediatrics 2007, 7:27 http://www.biomedcentral.com/1471-2431/7/27
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The intention of this study was to recruit infants between
the ages of 0 and 6 months. Although infants across this
entire age spectrum were recruited, numbers at the upper
end of this range were less than had been desired, reflect-
ing the visit and illness spectrum of this group and also
chance (Tables 4 and 5). For the 84 infants recruited, the
median age was 48 days, the mean age was 30 days and
only 20 infants fell into the 3–6 month age range. Thus
younger infants were represented strongly and older
infants were underrepresented in this study. Therefore we
could not draw valid conclusions about the effectiveness
of our interventions on infants older than 3 months of
age.
We also observed a higher standard deviation than we had
originally anticipated. As a result, statistical significance
was not achieved when examining age related effects
although intriguing trends towards significance were seen
which warrant further examination.
Conclusion
This study demonstrates that venipuncture in infants is a
moderately painful procedure. The use of pacifier with
sucrose as procedural analgesia for venipuncture in the
PED is effective in reduction of pain in infants 0–3
months old, as shown by decrease in crying times. Pacifi-
ers and sucrose are inexpensive, easy to use, have quick
onset, short duration of action, and no serious side effects.
They should be used in the pediatric emergency depart-
ment and other pediatric units to help prevent pain from
venipuncture for infants aged 0–3 months. Further study
to clarify effects of age and sucrose concentrations, as well
as effectiveness for other painful procedures is required.
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